Citation
Brandt, Tracy, et al. "Adapting ACMG/AMP Sequence Variant Classification Guidelines for Single-gene Copy Number Variants." Genetics in Medicine : Official Journal of the American College of Medical Genetics, vol. 22, no. 2, 2020, pp. 336-344.
Brandt T, Sack LM, Arjona D, et al. Adapting ACMG/AMP sequence variant classification guidelines for single-gene copy number variants. Genet Med. 2020;22(2):336-344.
Brandt, T., Sack, L. M., Arjona, D., Tan, D., Mei, H., Cui, H., Gao, H., Bean, L. J. H., Ankala, A., Del Gaudio, D., Knight Johnson, A., Vincent, L. M., Reavey, C., Lai, A., Richard, G., & Meck, J. M. (2020). Adapting ACMG/AMP sequence variant classification guidelines for single-gene copy number variants. Genetics in Medicine : Official Journal of the American College of Medical Genetics, 22(2), 336-344. https://doi.org/10.1038/s41436-019-0655-2
Brandt T, et al. Adapting ACMG/AMP Sequence Variant Classification Guidelines for Single-gene Copy Number Variants. Genet Med. 2020;22(2):336-344. PubMed PMID: 31534211.
TY - JOUR
T1 - Adapting ACMG/AMP sequence variant classification guidelines for single-gene copy number variants.
AU - Brandt,Tracy,
AU - Sack,Laura M,
AU - Arjona,Dolores,
AU - Tan,Duanjun,
AU - Mei,Hui,
AU - Cui,Hong,
AU - Gao,Hua,
AU - Bean,Lora J H,
AU - Ankala,Arunkanth,
AU - Del Gaudio,Daniela,
AU - Knight Johnson,Amy,
AU - Vincent,Lisa M,
AU - Reavey,Caitlin,
AU - Lai,Amy,
AU - Richard,Gabriele,
AU - Meck,Jeanne M,
Y1 - 2019/09/19/
PY - 2019/4/22/received
PY - 2019/9/3/accepted
PY - 2019/9/20/pubmed
PY - 2021/1/12/medline
PY - 2019/9/20/entrez
KW - ACMG/AMP criteria
KW - PVS1
KW - copy number variant (CNV)
KW - variant classification guidelines
KW - variant interpretation
SP - 336
EP - 344
JF - Genetics in medicine : official journal of the American College of Medical Genetics
JO - Genet Med
VL - 22
IS - 2
N2 - PURPOSE: The ability of a single technology, next-generation sequencing, to provide both sequence and copy number variant (CNV) results has driven the merger of clinical cytogenetics and molecular genetics. Consequently, the distinction between the definition of a sequence variant and a CNV is blurry. As the 2015 American College of Medical Genetics and Genomics/Association for Molecular Pathology (ACMG/AMP) standards and guidelines for interpretation of sequence variants address CNV classification only sparingly, this study focused on adapting ACMG/AMP criteria for single-gene CNV interpretation. METHODS: CNV-specific modifications of the 2015 ACMG/AMP criteria were developed and their utility was independently tested by three diagnostic laboratories. Each laboratory team interpreted the same 12 single-gene CNVs using three systems: (1) without ACMG/AMP guidance, (2) with ACMG/AMP criteria, and (3) with new modifications. A replication study of 12 different CNVs validated the modified criteria. RESULTS: The adapted criteria system presented here showed improved concordance and usability for single-gene CNVs compared with using the ACMG/AMP interpretation guidelines focused on sequence variants. CONCLUSION: These single-gene CNV criteria modifications could be used as a supplement to the ACMG/AMP guidelines for sequence variants, allowing for a streamlined workflow and a step toward a uniform classification system for both sequence and copy number alterations.
SN - 1530-0366
UR - https://www.unboundmedicine.com/medline/citation/31534211
DB - PRIME
DP - Unbound Medicine
ER -